A Study to Compare the Efficacy and Safety of LY01015 and Opdivo ® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Condition:   Esophageal Squamous Cell Carcinoma Interventions:   Drug: LY01015;   Drug: Fluorouracil;   Drug: Cisplatin;   Drug: Opdivo® Sponsor:   Shandong Boan Biotechnology Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials